Ose Immunotherapeutics annual revenue
2020
2021
2022
2023
2024
2025
Ose Immunotherapeutics Revenue Growth & History (OSE)
Ose Immunotherapeutics reported €2.6M in revenue for fiscal 2025, a decrease of 96.25% from the previous fiscal year.
View full Ose Immunotherapeutics company overviewOse Immunotherapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €2.6M | −€67.3M | −96.25% |
| 2024 | 2024-12-31 | €69.9M | €67.7M | +3037.72% |
| 2023 | 2023-12-31 | €2.2M | −€16.1M | −87.83% |
| 2022 | 2022-12-31 | €18.3M | −€8.0M | −30.43% |
| 2021 | 2021-12-31 | €26.3M | €15.9M | +152.17% |
| 2020 | 2020-12-31 | €10.4M | — | — |
Ose Immunotherapeutics revenue growth trends
Over the last five reported fiscal years, revenue declined from €10.4M to €2.6M, a compound annual decline of 24.15%.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Ose Immunotherapeutics source filings ↗